Suchergebnisse - "Retinitis pigmentosa"

PubPharm (4.774)

1

Disease modeling and pharmacological rescue of autosomal dominant retinitis pigmentosa associated with RHO copy number variation

enthalten in: eLife | 2024

von Kandoi, S. | Martinez, C. | Chen, K. | +5

2

Systematic study of ophthalmological findings in 10 patients with PEX1-mediated Zellweger spectrum disorder

enthalten in: Ophthalmic genetics | 2024

von Karuntu, J. | Klouwer, F. | Engelen, M. | +1

3

Cell Collection to Study Eye Diseases : Generation of Induced Pluripotent Stem (iPS) Cell Lines From Somatic Cells of Participants With Eye Diseases and From Somatic Cells of Matched Controls

enthalten in: ClinicalTrials.gov | 2024

4

The Zn2+ transporter ZIP7 enhances endoplasmic-reticulum-associated protein degradation and prevents neurodegeneration in Drosophila

enthalten in: Developmental cell | 2024

von Guo, X. | Mutch, M. | Torres, A. | +8

5

Syndromic Retinitis Pigmentosa : A 15-Patient Study

enthalten in: Genes | 2024

von Holanda, I. | Rim, P. | Rare Genomes Project Consortium | +3

6

Rod and Cone Mediated Function in Retinal Disease : Rod and Cone Mediated Function in Retinal Disease

enthalten in: ClinicalTrials.gov | 2024

7

A Clinical Trial Evaluating the Safety and Efficacy of a Single Subretinal Injection of AGTC-501 in Participants With XLRP : A Randomized, Controlled, Masked, Multi-center Study Evaluating the Efficacy, Safety, and Tolerability of Two Doses of AGTC-501 Compared to an Untreated Control Group in Male Participants With X-linked Retinitis Pigmentosa

enthalten in: ClinicalTrials.gov | 2024

8

Observational Study to Assess Endpoint Operational Feasibility & Measurement Properties in Retinitis Pigmentosa Patients : Observational, Non-Interventional Study to Determine the Operational Feasibility and Measurement Properties of Endpoints in Patients With Retinitis Pigmentosa

enthalten in: ClinicalTrials.gov | 2024

9

A Dose Ranging Study to Evaluate the Safety and Potential Efficacy of rhNGF in Patients With Retinitis Pigmentosa (RP) : A 24 Week Phase Ib/II, Multicenter, Randomized, Controlled, Parallel Group, Dose Ranging Study With a 24 Week Follow-up to Evaluate Safety and Potential Efficacy of 2 Doses (60, 180 µg/ml) of rhNGF Solution vs Vehicle in Patients With RP.

enthalten in: ClinicalTrials.gov | 2024

10

PDE6A Gene Therapy for Retinitis Pigmentosa : PIGMENT - PDE6A Gene Therapy for Retinitis Pigmentosa

enthalten in: ClinicalTrials.gov | 2024

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[478]